Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of TPP can prevent complications.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Long COVID patients may have hormonal imbalances linked to their symptoms.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Latanoprost may cause scalp inflammation and delayed healing.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

People with alopecia areata may be more likely to have a certain type of hearing loss.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.